Inhibikase Therapeutics (IKT) Operating Margin (2020 - 2023)
Inhibikase Therapeutics' Operating Margin was -440356600.00% in Q4 2023, down 440349780.36 percentage points from -6819.64% a year earlier and down 440350606.62 percentage points from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Operating Margin (2020 - 2023) Analysis & Trends
For FY2023, Operating Margin at Inhibikase Therapeutics came in at -7711.98%, up 6974.19 percentage points from FY2022.
- Operating Margin shows a three-year change of -7308.46 percentage points (FY2020 to FY2023).
- In earlier years, Operating Margin was -14686.17% in FY2022 (-14209.94 pp), -476.23% in FY2021 (-72.71 pp) and -403.52% in FY2020.
- The Q4 2023 figure marks the lowest quarterly Operating Margin in data going back to Q1 2020.
- Compared with a year earlier, Operating Margin was higher in four of the last eight quarters, with an average year-over-year change of -55014269.26 percentage points.
- The best year-over-year quarter for Operating Margin over five years was Q4 2022 (a gain of 252514.77 percentage points); the worst was Q4 2023 (a drop of 440349780.36 percentage points).
- Per Business Quant data, IKT's Operating Margin in the three quarters before Q4 2023 was -5993.38% (Q3 2023), -5328.07% (Q2 2023) and -7307.62% (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Inhibikase Therapeutics | 357.87 Mn | -227.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -440,356,600.00% |
| Sep 30, 2023 | -5,993.38% |
| Jun 30, 2023 | -5,328.07% |
| Mar 31, 2023 | -7,307.62% |
| Dec 31, 2022 | -6,819.64% |
| Sep 30, 2022 | -61,899.59% |
| Jun 30, 2022 | -70,817.14% |
| Mar 31, 2022 | -10,081.46% |
| Dec 31, 2021 | -259,334.41% |
| Sep 30, 2021 | -1,361.22% |
| Jun 30, 2021 | -192.83% |
| Mar 31, 2021 | -186.56% |
| Dec 31, 2020 | -704.66% |
| Sep 30, 2020 | -1,761.44% |
| Jun 30, 2020 | -188.50% |
| Mar 31, 2020 | -199.42% |
API Access
Inhibikase Therapeutics Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();